1. UCSD-Led Team Finds Leukemia-Killing Molecule

    UC San Diego researchers say they've found an immune system molecule that directly kills chronic lymphocytic leukemia cells without harming healthy ones. The molecule, called a monoclonal antibody, is being readied for human clinical trials in the not-too-distant future, lead researcher Thomas J. Kipps said. Kipps holds the Evelyn and Edwin Tasch Chair in Cancer Research at the UCSD Moores...
  2. Roscovitine: A Highly Selective CDK Inhibitor With Promising Oncology

    (R)-Roscovitine is often referred to as a “selective inhibitor of cyclin-dependent kinases.” Besides its use as a biological tool in cell cycle, neuronal functions, and apoptosis studies, it is currently evaluated as a potential drug to treat cancers, neurodegenerative diseases, viral infections, and glomerulonephritis.

2 Item(s)

To Top